Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07361367
PHASE1
A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants
Sponsor: AbbVie
View on ClinicalTrials.gov
Summary
The objective of this study is to evaluate the PK of a tablet formulation of ABBV-722 under fasted conditions and the effect of food on its bioavailability after administration of single doses
Official title: A Phase 1 Study to Evaluate the Pharmacokinetics of a Tablet Formulation of ABBV-722 and the Effect of Food on Its Bioavailability in Healthy Adult Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
11
Start Date
2026-01-15
Completion Date
2026-03
Last Updated
2026-02-24
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
ABBV-722
Oral Tablet
Locations (1)
Acpru /Id# 279291
Grayslake, Illinois, United States